Structural basis for physiological regulation of paracellular pathways in intestinal epithelia
Subcutaneous injection is the most common research-context format today, but no published human pharmacokinetic study has formally characterized subcutaneous AOD-9604 (this gap was specifically called out in FDA's December 2024 review)
Every protocol is reviewed by a Medical Director
The cell evidence establishes biological plausibility, not clinical proof
During its brief time in circulation, it rapidly engages cell receptors (like the Growth Hormone Receptors) and activates key signaling pathways (like the Akt-eNOS pathway) that initiate a long-lasting, sustained genetic expression program for tissue repair
Exercise capacity, measured by the 6-minute walk test, showed that 50% of ARA-290 patients could walk at least 25 meters more compared with only 12% of placebo patients